Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  3. NVAX
N

Novavax, Inc. (NVAX)

8.45

0.00 (0.00%)

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know
26.03.2026

Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know

In the most recent trading session, Novavax (NVAX) closed at $8.95, indicating a -4.18% shift from the previous trading day.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
23.03.2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.
17.03.2026

Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.

The first severe case of the virus has been detected in New York.

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
17.03.2026

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Novavax, Inc. (NVAX) Presents at Leerink Global Healthcare Conference 2026 Transcript
10.03.2026

Novavax, Inc. (NVAX) Presents at Leerink Global Healthcare Conference 2026 Transcript

Novavax, Inc. (NVAX) Presents at Leerink Global Healthcare Conference 2026 Transcript

Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript
03.03.2026

Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
03.03.2026

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Videos

No Data

There is no data to display

Press releases

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
26.02.2026

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed in 2025 and Q1 2026 with pharmaceutical companies, including major global pharmaceutical companies exploring the utility of Matrix-M for their vaccine portfolios Successful execution of Sanofi partnership with $225 million in milestones earned in full year 2025 Total revenue of $147 million in the fourth quarter of 2025 and $1.1 billion for the full year 2025 Continued advancement of early-stage pipeline with the intention to enter the clinic as early as 2027 Year end 2025 Cash of $751 million Novavax exceeded its full year 2025 R&D and SG&A expense reduction goals and is improving future targets GAITHERSBURG, Md., Feb. 26, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.

Novavax Announces Entering into a License Agreement with Pfizer
20.01.2026

Novavax Announces Entering into a License Agreement with Pfizer

Non-exclusive license allows for development by Pfizer to utilize Matrix-M ® for up to two disease areas with its products Provides Novavax with an upfront payment of $30 million with the potential for up to another $500 million in development and sales milestones. In addition to milestone payments, Novavax is eligible to receive high mid-single digit percentage royalties GAITHERSBURG, Md.

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
07.01.2026

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P.

Novavax to Participate in Jefferies London Healthcare Conference
12.11.2025

Novavax to Participate in Jefferies London Healthcare Conference

GAITHERSBURG, Md. , Nov. 12, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference: Jefferies London Healthcare Conference: Fireside Chat Date: Wednesday, November 19, 2025 Time: 4:30 p.m.